Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000461171 | SCV000552372 | likely benign | Tuberous sclerosis 1 | 2023-12-22 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV001011985 | SCV001172382 | likely benign | Hereditary cancer-predisposing syndrome | 2019-02-21 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Genome- |
RCV000461171 | SCV002041158 | benign | Tuberous sclerosis 1 | 2021-11-07 | criteria provided, single submitter | clinical testing | |
Sema4, |
RCV001011985 | SCV002530913 | uncertain significance | Hereditary cancer-predisposing syndrome | 2021-10-21 | criteria provided, single submitter | curation | |
All of Us Research Program, |
RCV000042047 | SCV004814307 | uncertain significance | Tuberous sclerosis syndrome | 2023-08-15 | criteria provided, single submitter | clinical testing | |
Gene |
RCV004721251 | SCV005327899 | uncertain significance | not provided | 2024-02-01 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 19747374) |
Tuberous sclerosis database |
RCV000042047 | SCV000065830 | not provided | Tuberous sclerosis syndrome | no assertion provided | curation | ||
Prevention |
RCV004745178 | SCV005357282 | uncertain significance | TSC1-related disorder | 2024-03-08 | no assertion criteria provided | clinical testing | The TSC1 c.153A>C variant is predicted to result in the amino acid substitution p.Glu51Asp. This variant has been reported in individual(s) with tuberous sclerosis complex (example, Table 2, van Slegtenhorst et al. 1999. PubMed ID: 10227394). Functional study has shown this variant was functionally neutral (Mozaffari et al. 2009. PubMed ID: 19747374). This variant is reported in 0.00088% of alleles in individuals of European (Non-Finnish) descent in gnomAD. Conflicting interpretations of pathogenicity of this variant range from benign to a variant of uncertain significance in Clinvar (https://www.ncbi.nlm.nih.gov/clinvar/variation/48800/). At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. |